Micro Emerging Active

ImmunityBio Lettera di avvertimento FDA

Punteggio
0,4
Velocità
▲ 0,0
Articoli
4
Fonti
1

Riepilogo

Un articolo appartiene a questa narrazione se tratta della lettera di avvertimento della FDA ricevuta da ImmunityBio.

Articoli Correlati

ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for Papillary-Only NMIBC

Yahoo Finance · Mar 25, 2026
Mixed

Why ImmunityBio Stock Is Down More Than 20% Today

Yahoo Finance · Mar 24, 2026
Bearish

Fonti

Jim Cramer on ImmunityBio: “I Would Encourage You to Own … Yahoo Finance
ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy … Yahoo Finance
ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include … Yahoo Finance
Why ImmunityBio Stock Is Down More Than 20% Today Yahoo Finance

Cronologia

Ultimo aggiornamento Mar 24, 2026